Wosulin-N 40IU/ml Suspension for Injection

Introduction

Wosulin-N is a prescription medication that contains the active ingredient Insulin Isophane. It is commonly prescribed to manage blood sugar levels in individuals with diabetes. Wosulin-N is available in the form of a suspension, making it easier to administer, particularly for patients who have difficulty swallowing pills.

Uses

Wosulin-N is primarily used to control blood sugar levels in individuals with diabetes. It is indicated for the treatment of both type 1 and type 2 diabetes. By mimicking the action of naturally produced insulin, Wosulin-N helps regulate glucose levels in the bloodstream and allows cells to effectively utilize glucose for energy.

Dosage and Administration

The dosage of Wosulin-N will be determined by your healthcare provider based on your individual needs and response to treatment. Follow the prescribed dosage instructions carefully. The medication is typically administered subcutaneously (under the skin) using a syringe or insulin pen.

Mechanism of Action

Insulin Isophane, the active ingredient in Wosulin-N, acts similarly to naturally produced insulin in the body. It works by binding to insulin receptors on cell surfaces, allowing glucose to enter the cells and be used for energy. This helps lower blood sugar levels and prevents hyperglycemia (high blood sugar).

Side Effects

Common side effects may include injection site reactions, such as redness, swelling, or itching. Other possible side effects include hypoglycemia (low blood sugar), weight gain, and allergic reactions. Monitor your blood sugar levels regularly and seek medical attention if you experience any severe or persistent side effects.

Drug Interactions

Wosulin-N may interact with certain medications, including oral diabetes medications, beta-blockers, and certain medications that affect blood clotting. Inform your healthcare provider about all the medications you are taking, including prescription, over-the-counter, and herbal products, to avoid potential drug interactions. They can provide guidance on how to manage these interactions effectively.

Precautions

Before using Wosulin-N, inform your healthcare provider about any medical conditions you have, especially liver or kidney problems. This medication may not be suitable for individuals with certain conditions or those who are allergic to any of its components. Additionally, Wosulin-N may interact with alcohol, so it is advisable to limit or avoid alcohol consumption while using this medication.

Storage

Wosulin-N should be stored in a cool, dry place away from direct sunlight. Keep the medication out of the reach of children and pets. Do not freeze the suspension. Always check the expiration date and discard any expired medication properly.

Patient Tips

• Follow your healthcare provider’s instructions on the use and administration of Wosulin-N.
• Monitor your blood sugar levels regularly and report any significant changes to your healthcare provider.
• Keep a record of your insulin doses and any side effects you experience.
• Carry a form of identification indicating that you are using insulin in case of emergencies.
• If you have any questions or concerns about Wosulin-N, don’t hesitate to consult your healthcare provider for clarification and guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Intermediate-acting insulin: a medicine to treat diabetes (NHS UK) [Accessed 11 Jun. 2024] (online) Available at:
• HUMULIN I (Isophane) 100IU/ml suspension for injection in cartridge (Health Professionals SmPC) Available at:
• Insulin isophane (Drugs.com) [Accessed 26 Jun. 2024] (online) Available at:
• insulin isophane pork pure suspension (OTC) [Accessed 5 Jun. 2024] (online) Available at:
• Insulin (Food and Drug Administration) [Accessed 16 Jun. 2024] (online) Available at:
• Horvath K, Jeitler K, Berghold A, Ebrahim SH, Gratzer TW, Plank J, Kaiser T, Pieber TR, Siebenhofer A. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005613. doi: 10.1002/14651858.CD005613.pub3. [Accessed 0 Jun. 2024] Available at: